EUVIMEDEUVIMED entdecken
Crossref

ATF3 Mediates the Immunoregulatory Role of the Tim‐3 Pathway in Primary Biliary Cholangitis

Jiamin Xu, Haitao Ma, Wenxia Yang, Rongfang Tu, Hua Lin, Yang Feng, Simiao Li, Weimin Bao, Yingmei Tang iD

Journal of Gastroenterology and Hepatology · 2026

DOI: 10.1111/jgh.70234 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Jiamin Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China. Hauptthemen laut MEDLINE: Hepatitis A Virus Cellular Receptor 2, Activating Transcription Factor 3, Liver Cirrhosis, Biliary, Signal Transduction. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Project of Central Government for Local Science and Technology Development, Yunnan Province Chen Jie Expert Workstation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The immune checkpoint Tim‐3 has been implicated in the pathogenesis of primary biliary cholangitis (PBC), but its precise role in modulating macrophage polarization and immune dysregulation remains unclear. This study aimed to define the expression patterns of Tim‐3 in PBC patients and elucidate its functional impact on macrophage behavior and disease progression.

Methods

Bulk RNA sequencing was performed using peripheral blood mononuclear cells (PBMCs) derived from PBC patients. The expression of Tim‐3 and Toll‐like receptor (TLR) 2 was assessed using flow cytometry. A murine model of autoimmune cholangitis was established using syngeneic bile duct protein. The Tim‐3/Galectin‐9 pathway was blocked using α‐lactose both in vivo and in vitro. Short hairpin RNA (shRNA)–mediated silencing of ATF3 expression was conducted in THP‐1 cells to explore its role in macrophage regulation.

Results

Our results revealed a significant pro‐inflammatory innate immune response in the periphery of PBC patients. Advanced PBC patients exhibited reduced M2‐like Kupffer cells and decreased expression of Tim‐3 and ATF3, whereas Galectin‐9 expression was upregulated. TLR2 activation downregulated Tim‐3 and ATF3 expression in macrophages. Blockade of the Tim‐3/Galectin‐9 pathway with α‐lactose exacerbated experimental autoimmune cholangitis, reduced M2 Kupffer cells and ATF3 expression, and increased CXCL10 levels in the liver. Furthermore, silencing ATF3 impaired the suppressive effects of the Tim‐3/Galectin‐9 pathway on TLR2‐activated macrophages and primary murine Kupffer cells.

Conclusion

These findings highlight the prominent pro‐inflammatory innate immune response in PBC patients and demonstrate that ATF3 partially mediates the immunomodulatory effects of the Tim‐3/Galectin‐9 pathway on macrophages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis A Virus Cellular Receptor 2Activating Transcription Factor 3Liver Cirrhosis, BiliarySignal TransductionAnimalsHumansGalectinsToll-Like Receptor 2Disease Models, AnimalMacrophagesImmunity, InnateFemaleGene ExpressionDisease ProgressionMiceKupffer Cells

Stichwörter der Autor:innen

ATF3TLR2Tim‐3macrophageprimary biliary cholangitis

Substanzen

Hepatitis A Virus Cellular Receptor 2Activating Transcription Factor 3HAVCR2 protein, humanGalectinsToll-Like Receptor 2LGALS9 protein, humanATF3 protein, humanTLR2 protein, humangalectin 9, mouseTlr2 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Yunnan Liver Disease Research Center, Kunming, Yunnan, China.
  • Department of Clinical Laboratory, Yunnan Molecular Diagnostic Center, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Department of Colorectal Surgery, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.

ORCID-Profile: Yingmei Tang

Förderung

  • National Natural Science Foundation of China
  • Special Project of Central Government for Local Science and Technology Development
  • Yunnan Province Chen Jie Expert Workstation
  • Medicine Leading Talents of Yunnan Province
  • Yunnan Revitalization Talent Support Program
  • Postdoctoral Program of Yunnan Province

Zitieren

APA

Xu, J., Ma, H., Yang, W., Tu, R., Lin, H., Feng, Y., Li, S., Bao, W., & Tang, Y. (2026). ATF3 Mediates the Immunoregulatory Role of the Tim‐3 Pathway in Primary Biliary Cholangitis. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70234

Vancouver

Xu J, Ma H, Yang W, Tu R, Lin H, Feng Y, et al. ATF3 Mediates the Immunoregulatory Role of the Tim‐3 Pathway in Primary Biliary Cholangitis. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70234

BibTeX
@article{Xu2026,
  author = {Xu, Jiamin and Ma, Haitao and Yang, Wenxia and Tu, Rongfang and Lin, Hua and Feng, Yang and Li, Simiao and Bao, Weimin and Tang, Yingmei},
  title = {ATF3 Mediates the Immunoregulatory Role of the Tim‐3 Pathway in Primary Biliary Cholangitis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  doi = {10.1111/jgh.70234}
}
Kostenlos starten →